Taylor & Francis

Inhibition of PI3K pathway increases immune infiltrate in muscle-invasive bladder cancer Edith Borcoman, Philippe De La Rochere, Wilfrid Richer -OncoImmunology   " Although immune checkpoint inhibitors have shown improvement in survival in comparison to chemotherapy in urothelial bladder cancer, many patients ..." | Read Full Text >

Check out what else is new for you this week...

Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy Romain-David Seban, Charlotte Robert, Laurent Dercle - OncoImmunology   " The aim of this study was to evaluate if bone marrow (BM) SUVmax measured on pre-treatment 18F-FDG PET/CT predicts the clinical outcome of locally advanced cervical cancer" | Read Full Text >         SpCas9-expression by tumor cells can cause T cell-dependent tumor rejection in immunocompetent mice Reham Ajina, Danielle Zamalin, Annie Zuo - OncoImmunology   " The CRISPR/Cas9 system has recently emerged as a highly efficient modality in genetic engineering and has been widely considered for various therapeutic applications. Howev" | Read Full Text >         Efficacy and safety of immune checkpoint inhibitors in advanced gastric or gastroesophageal junction cancer: A systematic review and meta-analysis Cong Chen, Fan Zhang, Ning Zhou - OncoImmunology   " Background : Immune checkpoint inhibitors (ICI) have shown promising prospects in gastroesophageal junction (G/GEJ) cancer immunotherapy, many clinical trials h" | Read Full Text >         Sub-Cutaneous Fat Mass measured on multislice computed tomography of pretreatment PET/CT is a prognostic factor of stage IV non-small cell lung cancer treated by nivolumab. Geoffrey Popinat, Stéphanie Cousse, Lucas Goldfarb - OncoImmunology   " Introduction : Our aim was to explore the prognostic value of anthropometric parameters in patients treated with nivolumab for stage IV non-small cell lung canc" | Read Full Text >